Lucid Diagnostics Inc (LUCD)

NASDAQ
3.35
-0.04(-1.18%)
After Hours
3.39
+0.04(+1.19%)
- Real-time Data
  • Volume:
    137,516
  • Day's Range:
    3.30 - 3.55
  • 52 wk Range:
    1.69 - 13.52

LUCD Overview

Prev. Close
3.39
Day's Range
3.3-3.55
Revenue
690K
Open
3.55
52 wk Range
1.69-13.52
EPS
-
Volume
137,516
Market Cap
128.16M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
103,167
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
38,255,407
Next Earnings Date
Aug 15, 2022
What is your sentiment on Lucid Diagnostics?
or
Market is currently closed. Voting is open during market hours.

Lucid Diagnostics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Lucid Diagnostics Inc Company Profile

Lucid Diagnostics Inc Company Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellBuyStrong BuyNeutral
Technical IndicatorsStrong SellBuySellStrong BuyBuy
SummaryStrong SellNeutralNeutralStrong BuyNeutral